The adverse events of increased hepatic enzymes, lymphopenia, urinary tract infection, increased alanine aminotransferase level, increased γ-glutamyltransferase level, and decreased lymphocyte count were reported with higher frequency in the fingolimod groups. Here, GPT is linked to lymphopenia.